对基于应用程序的健康干预措施的有效性和疗效试验进行总体审查
Sherry On Ki Chong1, Sara Pedron2, Nancy Abdelmalak2
1Professorship of Public Health and Prevention, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany. sherry.chong@tum.de.
NPJ digital medicine
|December 16, 2023
概括
移动健康应用程序显示出患者自我管理的前景. 这一综合性审查发现,虽然健康应用程序可能会改善结果,但它们的有效性因病情而异,需要进一步研究行为影响.
科学领域:
- 数字健康数字健康
- 医疗保健服务研究 医疗服务研究
- 证据综合 证据综合
背景情况:
- 移动电话和平板电脑应用程序 (APP) 越来越多地用于健康干预.
- 随机对照试验 (RCT) 为这些数字健康工具的有效性和有效性提供了越来越多的证据.
- 患者可以通过基于应用程序的干预措施更有效地管理他们的健康状况.
研究的目的:
- 绘制和总结已发表的关于基于移动应用程序的健康干预措施在患者群体中的有效性和有效性的系统审查.
- 综合来自高质量的系统审查评估健康应用程序干预措施的证据.
- 为了识别健康应用程序在不同医疗适应症中的有效性变化.
主要方法:
- 采用了一种总体审查方法,遵循预先规定的协议.
- 评估健康应用干预措施的RCT的系统审查在两个数据库中搜索到2023年8月28日.
- 使用AMSTAR2工具评估了方法质量,并提取了有关指示,结果和应用特征的数据.
主要成果:
- 48项系统性审查 (2013-2023年),包括35项具有元分析的系统性审查,符合纳入标准.
- 评论涵盖了一系列疾病,特别关注糖尿病,焦虑和抑郁症.
- 41项审查得出结论,健康应用程序可能有效地改善健康结果,尽管有效性因适应症而异.
结论:
- 综合证据表明,健康应用程序的有效性在不同的医疗状况中存在显著差异.
- 建议进行进一步的随机对照试验 (RCT),以报告行为结果和医疗保健资源利用情况.
- 了解有效的健康应用程序的机制和医疗保健系统影响需要进行更详细的调查.
相关概念视频
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Hazard Ratio
130
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
130


